Freedom of Information Request ID
10183
Date of response
November 2025
I am conducting analysis on the diagnosis of Alzheimer’s Disease and would be grateful if you could answer the questions below for all relevant activity within the Trust.
- Where, if at all, does the Trust carry out lumbar punctures (cerebrospinal fluid) for diagnosing patients with Alzheimer’s Disease?
- Please provide a list of the full names of other Trusts or other organisations to which the Trust refers patients for lumbar punctures in the diagnosis of Alzheimer’s Disease.
- How many lumbar punctures to test for Alzheimer’s Disease took place in the last three-month period for which data are available?
- How many blood-based biomarker (BBBM) tests for Alzheimer’s Disease were conducted during the last three-month period?
- Where, if at all, does the Trust carry out Blood-based Biomarker (BBBM) tests for diagnosing NHS patients with Alzheimer’s Disease?
- Please provide a list of the full names of other Trusts or other organisations, to which the Trust refers Blood-based Biomarker tests for the diagnosis of Alzheimer’s Disease for NHS patients.
- Which biomarker tests are used to detect Alzheimer’s Disease for patients in the care of the Trust, whether the BBBM tests are carried out within or outside of the Trust?
- How many pTau181 immunoassay tests were conducted to test for Alzheimer’s Disease in the last three-months?
- Is pTau181 testing for Alzheimer’s Disease linked to, or conducted in conjunction with, clinical trials?
- How many pTau181 immunoassay tests were conducted for Alzheimer’s Disease as part of a clinical trial?
- How many pTau217 immunoassay tests were conducted to test for Alzheimer’s Disease in the last three-months?
- Is pTau217 testing for Alzheimer’s Disease linked to, or conducted in conjunction with, clinical trials?
- How many pTau217 immunoassay tests were conducted for Alzheimer’s Disease as part of a clinical trial?
- Does your organisation participate in any of the following clinical trials?
- A) Which of the following metrics are used by the Trust to measure Blood-based Biomarker (BBBM) in the diagnosis of Alzheimer’s Disease?
B) Please can you help us understand how your centre defines the following: Number of tests, Number of kits, Number of runs, Number of units
FOI Requests
The Freedom of Information Act 2000 provides people with a right of access to a wide range of information held by public authorities, including the NHS.
FOI Disclosure Log
A collection of the most common FOI requests we have received and responded to.